Methscopolamine (bromide) structure
|
Common Name | Methscopolamine (bromide) | ||
|---|---|---|---|---|
| CAS Number | 155-41-9 | Molecular Weight | 398.292 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C18H24BrNO4 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | N/A | |
| Symbol |
GHS07, GHS09 |
Signal Word | Warning | |
Use of Methscopolamine (bromide)Methscopolamine (Pamine) is a muscarinic acetylcholine receptor blocker. Target: mAChRMethylscopolamine is an oral medication used along with other medications to treat peptic ulcers by reducing stomach acid secretion. With the advent of proton pump inhibitors and antihistamine medications it is rarely used for this. It can also be used for stomach or intestinal spasms, to reduce salivation, and to treat motion sickness. From Wikipedia.Methscopolamine (Pamine), an anti-acetylcholine drug, prevented ulcer formation, reduced further volume and acid output but produced a 3-4 fold increase in hexosamine concentration. Tissue (corpus and antrum) hexosamine was moderately reduced by restraint. In the corpus, this was counteracted by methscopolamine but antrum hexosamine was not influenced by this drug. The anti-ulcer property of methscopolamine may be due not only to its effect on acid secretion but also to the rise in gastric mucus concentration that it produced [1]. |
| Name | scopolamine methobromide |
|---|---|
| Synonym | More Synonyms |
| Description | Methscopolamine (Pamine) is a muscarinic acetylcholine receptor blocker. Target: mAChRMethylscopolamine is an oral medication used along with other medications to treat peptic ulcers by reducing stomach acid secretion. With the advent of proton pump inhibitors and antihistamine medications it is rarely used for this. It can also be used for stomach or intestinal spasms, to reduce salivation, and to treat motion sickness. From Wikipedia.Methscopolamine (Pamine), an anti-acetylcholine drug, prevented ulcer formation, reduced further volume and acid output but produced a 3-4 fold increase in hexosamine concentration. Tissue (corpus and antrum) hexosamine was moderately reduced by restraint. In the corpus, this was counteracted by methscopolamine but antrum hexosamine was not influenced by this drug. The anti-ulcer property of methscopolamine may be due not only to its effect on acid secretion but also to the rise in gastric mucus concentration that it produced [1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C18H24BrNO4 |
|---|---|
| Molecular Weight | 398.292 |
| Exact Mass | 397.088867 |
| PSA | 59.06000 |
| Index of Refraction | -24 ° (C=1, H2O) |
| InChIKey | LZCOQTDXKCNBEE-XJMZPCNVSA-N |
| SMILES | C[N+]1(C)C2CC(OC(=O)C(CO)c3ccccc3)CC1C1OC12 |
| Water Solubility | H2O: 50 mg/mL |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Symbol |
GHS07, GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H312 + H332-H400 |
| Precautionary Statements | P261-P280 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | T,N |
| Risk Phrases | 23/24/25-50/53-20/21/22 |
| Safety Phrases | 36/37/39-45-61-60-36/37 |
| RIDADR | UN 1544 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | YM3675000 |
| Packaging Group | III |
| HS Code | 2934999090 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
|
New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
Biochem. Pharmacol. 90(3) , 307-19, (2014) Activation of G protein-coupled receptors involves major conformational changes of the receptor protein ranging from the extracellular transmitter binding site to the intracellular G protein binding s... |
|
|
The development of anticholinergics in the management of COPD.
Int. J. Chron. Obstruct. Pulmon. Dis. 2(1) , 33-40, (2007) Anticholinergics have been used to treat obstructive respiratory disease for many years from historical preparations of the deadly nightshade genus, to the more recent developments ofipratropium, oxit... |
|
Name: Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay
Source: ChEMBL
Target: N/A
External Id: CHEMBL1266185
|
|
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ago...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_AG_FLUO8_1536_1X%ACT PRUN
|
|
Name: Cytochrome P450 Family 1 Subfamily A Member 2 (CYP1A2) small molecule antagonists: lu...
Source: 824
External Id: CYP273
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify pos...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_PAM_FLUO8_1536_1X%ACT PRUN
|
|
Name: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen
Source: NCGC
Target: N/A
External Id: SMAD3201
|
|
Name: uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay
Source: Burnham Center for Chemical Genomics
Target: cystic fibrosis transmembrane conductance regulator [Homo sapiens]
External Id: SBCCG-A764-CF-PAF-Primary-Assay
|
|
Name: Fluorescence-based cell-based primary high throughput screening assay to identify ant...
Source: The Scripps Research Institute Molecular Screening Center
Target: muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id: CHRM1_ANT_FLUO8_1536_1X%INH PRUN
|
|
Name: Primary qHTS for inhibitors of NSP2Pro chikungunya virus (CHIKV)
Source: NCGC
External Id: APP-Toga-CHIKV-nsp2-p
|
| Epoxymethamine bromide |
| Nutrop |
| Methylscopolamine bromide |
| (1R,2R,4S,5S,7s)-7-{[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0]nonane bromide |
| N-Methylscopolamine Bromide |
| UNII-RTN51LK7WL |
| 3-Oxa-9-azoniatricyclo[3.3.1.0]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, bromide, (1R,2R,4S,5S)- (1:1) |
| (-)-Tropic acid Ester with 6b,7b-Epoxy-3a-hydroxy-8-methyl-1aH,5aH-tropanium Bromide |
| (-)-Scopolamine Methobromide |
| Neo-avagal |
| N-Methylhyoscine bromide |
| N-methyl scopolammonium bromide |
| Scopolamine methobromide |
| Methscopolamine (bromide) |
| Restropin |
| Scopolamin methylbromide |
| scopolamine methylbromide |
| Holopan |
| (−)-Scopolamine methyl bromide Hyoscine methyl bromide Methscopolamine bromide |
| 6b,7b-Epoxy-3a-hydroxy-8-methyl-1aH,5aH-tropanium Bromide |
| Paraspan |
| EINECS 205-844-5 |
| Lescopine bromide |
| (-)-N-methylscopolamine bromide |
| [7(S)-(1a,2b,4b,5a,7b)]-7-(3-Hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide |
| Methylbromide Scopolamine |
| Pamine |
| Pamine Bromide |
| Methscopolamine Bromide |
| Blocan |
| N-Methylscopolammonium bromide |
| (1a,2b,4b,5a,7b)-7-[(2S)-3-Hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide |
| Methscopolamine methylbromide |
| MFCD00078560 |
| Diopal |
| Holopon |
| Hyoscine methyl bromide |
| Proscomide |
| Mescopil |
| (−)-Scopolamine methyl bromide |
| Hyoscine methyl bromide Methscopolamine bromide |
| Scopolamine Methyl Bromide |
| Ampyrox |
| Methscopolamine |
| Oxitropium bromide impurity B |